Latest Tercica Stories

2009-02-25 05:00:00

SOUTH SAN FRANCISCO, Calif., Feb. 25 /PRNewswire/ -- Proteolix, Inc., a leader in the discovery and development of novel therapeutics that target protein degradation pathways in cancer and autoimmune diseases, today announced the appointment of John A.

2008-11-14 09:00:34

Ambrx, a clinical stage biopharmaceutical company, has announced positive Phase I/II clinical trial data demonstrating that ARX201, the company's long-acting human growth hormone analogue developed in collaboration with Merck Serono, normalized insulin-like growth factor I levels while delivering an acceptable safety and tolerability profile in adults with growth hormone deficiency.

2008-10-17 03:00:16

Regulatory News: Ipsen (Paris:IPN) announced today that stockholders of Tercica, Inc. (Nasdaq:TRCA) voted to approve its previously announced acquisition of Tercica at a special meeting of shareholders held on 16 October 2008 in Brisbane, California.

2008-06-16 15:00:49

Tercica, Inc. (NASDAQ: TRCA) today announced the first results from the Increlex(R) Growth Forum Database (IGFD) Registry in two posters presented at the 90th annual meeting of the Endocrine Society in San Francisco.

Word of the Day
  • To say in too many words; to express verbosely.
  • To express in too many words: sometimes used reflexively.
  • The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.
The word 'overword' comes from over- +‎ word.